DZK-Stellungnahme zu Tuberkulose, BCG und COVID-19*

R. Otto-Knapp; B. Häcker; C. Breuer; R. Diel; S. H. E. Kaufmann; G. Korr; M. Pfeiffer; T. Schaberg; N. Schönfeld; P. Witte; T. Bauer

doi:10.1055/a-1199-6721

Pneumologie 2020; 74(07): 412-416
DOI: 10.1055/a-1199-6721

Stellungnahme

DZK-Stellungnahme zu Tuberkulose, BCG und COVID-19*

(*Offizielle Bezeichnung der Erkrankung durch das neuartige Coronavirus SARS-CoV-2, severe acute respiratory syndrome coronavirus 2)DZK Recommendations for Tuberculosis, BCG and COVID-19 in Germany(Official Abbreviation of Coronavirus Disease 2019 Caused by the New Coronavirus SARS-CoV-2)

R. Otto-Knapp

¹Deutsches Zentralkomitee zur Bekämpfung der Tuberkulose e. V. (DZK)

,

B. Häcker

¹Deutsches Zentralkomitee zur Bekämpfung der Tuberkulose e. V. (DZK)

,

C. Breuer

¹Deutsches Zentralkomitee zur Bekämpfung der Tuberkulose e. V. (DZK)

²Gesundheitsamt Dresden, Dresden

,

R. Diel

¹Deutsches Zentralkomitee zur Bekämpfung der Tuberkulose e. V. (DZK)

³LungenClinic Grosshansdorf, Airway Disease Center North (ARCN), Großhansdorf

,

S. H. E. Kaufmann

⁴Max-Planck-Institut für Infektionsbiologie, Berlin

,

G. Korr

⁵Bundesministerium für Gesundheit, Berlin

,

M. Pfeiffer

¹Deutsches Zentralkomitee zur Bekämpfung der Tuberkulose e. V. (DZK)

⁶Klinik Donaustauf, Universitätsklinikum Regensburg, Regensburg

⁷Deutsche Gesellschaft für Pneumologie e. V. (DGP)

,

T. Schaberg

¹Deutsches Zentralkomitee zur Bekämpfung der Tuberkulose e. V. (DZK)

,

N. Schönfeld

¹Deutsches Zentralkomitee zur Bekämpfung der Tuberkulose e. V. (DZK)

⁸Helios Klinikum Emil von Behring, Lungenklinik Heckeshorn, Berlin

,

P. Witte

¹Deutsches Zentralkomitee zur Bekämpfung der Tuberkulose e. V. (DZK)

⁹Institut für Krankenhaushygiene der Mühlenkreiskliniken, Universitätsklinikum Johannes-Wesling Minden

,

T. Bauer

¹Deutsches Zentralkomitee zur Bekämpfung der Tuberkulose e. V. (DZK)

⁷Deutsche Gesellschaft für Pneumologie e. V. (DGP)

⁸Helios Klinikum Emil von Behring, Lungenklinik Heckeshorn, Berlin

› Author Affiliations

Abstract

Full Text

References

Literatur
1 Global tuberculosis report 2019. Geneva: World Health Organization; 2019 Licence: CC BY-NC-SA 3.0 IGO
2 Glaziou P. Predicted impact of the COVID-19 pandemic on global tuberculosis deaths in 2020. medRxiv 2020;
3 Stop TB Partnership. The potential impact of the COVID-19 response on tuberculosis in high-burden countries: a modelling analysis. Im Internet (Stand: 09.06.2020): http://www.stoptb.org/covid19.asp
4 World Health Organization (WHO). Information Note Tuberculosis and COVID-19: Considerations for tuberculosis (TB) care. 2020 Im Internet (Stand: 09.06.2020): https://www.who.int/news-room/detail/12-05-2020-updated-who-information-note-ensuring-continuity-of-tb-services-during-the-covid-19-pandemic
5 Adepoju P. Tuberculosis and HIV responses threatened by COVID-19. Lancet HIV 2020; 7: e319-e320
6 Union warns the COVID-19 pandemic must not divert attention from the needs of children and adolescents in TB-endemic African countries. Im Internet (Stand: 09.05.2020): https://www.theunion.org/news-centre/news/union-warns-the-covid-19-pandemic-must-not-divert-attention-from-the-needs-of-children-and-adolescents-in-tb-endemic-african-countries
7 Robert Koch-Institut. Epidemiologisches Bulletin 11/2020. 2020 Im Internet (Stand: 09.05.2020): https://www.rki.de/DE/Content/Infekt/EpidBull/Archiv/2020/11/Tabelle.html
8 Tadolini M, Codecasa LR, García-García J-M. et al. Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases. Eur Respir J 2020; 2001398
9 Ravimohan S, Kornfeld H, Weissman D. et al. Tuberculosis and lung damage: from epidemiology to pathophysiology. Eur Respir Rev 2018; 27: 170077
10 Gupte AN, Paradkar M, Selvaraju S. et al. Assessment of lung function in successfully treated tuberculosis reveals high burden of ventilatory defects and COPD. PloS One 2019; 14: e0217289
11 Lee C-H, Lee M-C, Lin H-H. et al. Pulmonary tuberculosis and delay in anti-tuberculous treatment are important risk factors for chronic obstructive pulmonary disease. PloS One 2012; 7: e37978
12 International Union Against Tuberculosis and Lung Disease. COVID-19 and lung health: Frequently Asked Questions. Im Internet (Stand: 09.05.2020): https://www.theunion.org/news-centre/covid-19/covid-tb-faqs#five
13 Deutsche Gesellschaft für Pneumologie (DGP). Stellungnahme - Risikoabschätzung bei Patienten mit chronischen Atemwegs- und Lungenerkrankungen im Rahmen der SARS-CoV-2-Pandemie. 2020 Im Internet (Stand: 09.06.2020): https://pneumologie.de/aktuelles-service/covid-19/
14 Alqahtani JS, Oyelade T, Aldhahir AM. et al. Prevalence, Severity and Mortality associated with COPD and Smoking in patients with COVID-19: A Rapid Systematic Review and Meta-Analysis. PloS One 2020; 15: e0233147
15 Guo FR. Smoking links to the severity of Covid-19: An update of a meta-analysis. J Med Virol 2020; [Online ahead of print]
16 Deutsche Gesellschaft für Pneumologie (DGP). COVID-19. Im Internet (Stand: 09.06.2020): https://pneumologie.de/aktuelles-service/covid-19/
17 He G, Wu J, Shi J. et al. COVID-19 in Tuberculosis patients: a report of three cases. J Med Virol 2020;
18 Liu Y, Bi L, Chen Y. et al. Active or latent tuberculosis increases susceptibility to COVID-19 and disease severity. medRxiv 2020;
19 Stochino C, Villa S, Zucchi P. et al. Clinical characteristics of COVID-19 and active tuberculosis co-infection in an Italian reference hospital. Eur Respir J 2020; 2001708
20 Saunders MJ, Evans CA. COVID-19, tuberculosis, and poverty: preventing a perfect storm. Eur Respir J 2020; 2001348
21 Rosenbaum L. The Untold Toll – The Pandemic’s Effects on Patients without Covid-19. N Engl J Med 2020;
22 Schaberg T, Bauer T, Brinkmann F. et al. [Tuberculosis Guideline for Adults – Guideline for Diagnosis and Treatment of Tuberculosis including LTBI Testing and Treatment of the German Central Committee (DZK) and the German Respiratory Society (DGP)]. Pneumologie 2017; 71: 325-397
23 Pai M, Behr MA, Dowdy D. et al. Tuberculosis. Nat Rev Dis Primer 2016; 2: 16076
24 Drain PK, Bajema KL, Dowdy D. et al. Incipient and Subclinical Tuberculosis: a Clinical Review of Early Stages and Progression of Infection. Clin Microbiol Rev 2018; 31: e00021-18
25 World Health Organization. Scientific Brief – Bacille Calmette-Guérin (BCG) vaccination and COVID-19. 2020 Im Internet (Stand: 09.05.2020): https://www.who.int/news-room/commentaries/detail/bacille-calmette-gu%C3%A9rin-(bcg)-vaccination-and-covid-19
26 Schaaf HS, du Preez K, Kruger M. Bacille Calmette-Guérin (BCG) vaccine and the COVID-19 pandemic: responsible stewardship is needed. 2020 Im Internet (Stand: 09.05.2020): https://www.theunion.org/news-centre/news/bcg-vaccine-and-covid-19-responsible-stewardship-is-needed
27 Marais BJ, Seddon JA, Detjen AK. et al. Interrupted BCG vaccination is a major threat to global child health. Lancet Respir Med 2016; 4: 251-253
28 Kontturi A, Santiago B, Tebruegge M. et al. The impact of Bacille Calmette-Guerin shortage on immunisation practice and policies in Europe – A Paediatric Tuberculosis Network European Trials Group (ptbnet) survey. Tuberc 2016; 101: 125-129
29 Moorlag SJCFM, Arts RJW, van Crevel R. et al. Non-specific effects of BCG vaccine on viral infections. Clin Microbiol Infect 2019; 25: 1473-1478
30 Miller A, Reandelar MJ, Fasciglione K. et al. Correlation between universal BCG vaccination policy and reduced morbidity and mortality for COVID-19: an epidemiological study. medRxiv 2020;
31 Berg MK, Yu Q, Salvador CE. et al. Mandated Bacillus Calmette-Guérin (BCG) vaccination predicts flattened curves for the spread of COVID-19. medRxiv 2020;
32 Hensel J, McGrail DJ, McAndrews KM. et al. Exercising caution in correlating COVID-19 incidence and mortality rates with BCG vaccination policies due to variable rates of SARS CoV-2 testing. medRxiv 2020;
33 Kumar J, Meena J. Demystifying BCG Vaccine and COVID-19 Relationship. Indian Pediatr 2020; 57: 588-589
34 Hamiel U, Kozer E, Youngster I. SARS-CoV-2 Rates in BCG-Vaccinated and Unvaccinated Young Adults. JAMA 2020; e208189
35 O’Neill LAJ, Netea MG. BCG-induced trained immunity: can it offer protection against COVID-19?. Nat Rev Immunol 2020; 20: 335-337
36 Redelman-Sidi G. Could BCG be used to protect against COVID-19?. Nat Rev Urol 2020; 17: 316-317
37 Lawton G. Trials of BCG vaccine will test for covid-19 protection. New Sci 1971 2020; 246: 9
38 World Health Organization. BCG vaccines: WHO position paper – February 2018. Vaccins BCG: Note de synthèse de l’OMS – Février 2018. Wkly Epidemiol Rec 2018; 93: 73-96
39 Trunz BB, Fine P, Dye C. Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-ana-lysis and assessment of cost-effectiveness. Lancet 2006; 367: 1173-1180
40 Cernuschi T, Malvolti S, Nickels E. et al. Bacillus Calmette-Guérin (BCG) vaccine: A global assessment of demand and supply balance. Vaccine 2018; 36: 498-506
41 Roy P, Vekemans J, Clark A. et al. Potential effect of age of BCG vaccination on global paediatric tuberculosis mortality: a modelling study. Lancet Glob Health 2019; 7: e1655-e1663
42 du PreezK, Seddon JA, Schaaf HS. et al. Global shortages of BCG vaccine and tuberculous meningitis in children. Lancet Glob Health 2019; 7: e28-e29